Cargando…
Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson’s Disease — The RESISTA-PD Trial
The composition of the gut microbiota is linked to multiple diseases, including Parkinson’s disease (PD). Abundance of bacteria producing short-chain fatty acids (SCFAs) and fecal SCFA concentrations are reduced in PD. SCFAs exert various beneficial functions in humans. In the interventional, monoce...
Autores principales: | Becker, Anouck, Schmartz, Georges Pierre, Gröger, Laura, Grammes, Nadja, Galata, Valentina, Philippeit, Hannah, Weiland, Jacqueline, Ludwig, Nicole, Meese, Eckart, Tierling, Sascha, Walter, Jörn, Schwiertz, Andreas, Spiegel, Jörg, Wagenpfeil, Gudrun, Faßbender, Klaus, Keller, Andreas, Unger, Marcus M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684155/ https://www.ncbi.nlm.nih.gov/pubmed/34839011 http://dx.doi.org/10.1016/j.gpb.2021.08.009 |
Ejemplares similares
-
Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota
por: Weis, Severin, et al.
Publicado: (2019) -
Short-chain fatty acids and intestinal inflammation in multiple sclerosis: modulation of female susceptibility by microbial products?
por: Becker, Anouck, et al.
Publicado: (2021) -
Association between Parkinson’s disease and the faecal eukaryotic microbiota
por: Weis, Severin, et al.
Publicado: (2021) -
Prospect and challenge of detecting dynamic gene copy number increases in stem cells by whole genome sequencing
por: Fischer, Ulrike, et al.
Publicado: (2019) -
Gene amplification in mesenchymal stem cells and during differentiation towards adipocytes or osteoblasts
por: Altmayer, Nora Corinna, et al.
Publicado: (2017)